Delivery Order SPE2DB20D2014-SPE2DB25FC08K
- Not listed
- The Defense Logistics Agency awarded a $30,399.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of September 8, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a $15,593.79 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg tablets, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply arrangements with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for 60 tablets of Eliquis 5 mg at a ceiling value of $20,974.50. This competitively awarded, non-set-aside contract was executed on September 5, 2025, with an ultimate completion date of September 8, 2025. The firm fixed price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a $14,034.53 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $3,676.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product supporting federal medical procurement needs. This non-competitive delivery order, issued on June 2, 2025 with completion targeted for June 3, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under the company's broader contract...
- The Defense Logistics Agency awarded a $18,237.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of August 15, 2025. This non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems through...
- The Defense Logistics Agency awarded a $49,905.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-count packages of Eliquis 5 mg tablets, with an ultimate completion date of June 3, 2025. This non-competitive delivery order was issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $3,967.45 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on August 18, 2025, with an ultimate completion date of August 19, 2025. The contract carries firm fixed pricing with no set-aside designation, indicating competitive award under open procurement. Performance will be fulfilled from the vendor's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $25,380.07 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a firm fixed price contract type. The award was competitively procured with no set-aside designation and is scheduled for completion by June 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which falls under the company's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg tablets, with an ultimate completion date of September 16, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award status. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC08KDelivery Order
The Defense Logistics Agency awarded a $3,931.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with performance in Conshohocken, Pennsylvania and completion scheduled for June 2, 2025. This non-set-aside award represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling value extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of pharmaceuticals and medical supplies to support military and veteran healthcare systems. The delivery order falls within AmerisourceBergen's extensive portfolio of competitively awarded contracts with the Defense Logistics Agency Medical Supply Chain, which includes specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This award demonstrates the company's capability to fulfill federal medical procurement requirements on an open-competition basis and supports the broader Defense Health Agency mission to maintain adequate pharmaceutical inventory for military healthcare programs. The Eliquis delivery represents routine pharmaceutical procurement under the prime IDC vehicle that enables flexible global pharmaceutical support for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 5/30/25 |